Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
pyroglutamic (5-oxoproline) acidosis pyroglutamic (5-oxoproline) acidosis pathophysiology pathogenesis of pyroglutamic acidosis The primary driver may be cysteine deficiency : Cysteine deficiency causes glutamylcysteine to be shunted into 5-oxoproline
This publication is the result of many months of searching, screening, extracting data, analysing evidence, discussing interpretations, revising manuscripts, and learning along the way
LahrouchiNLodderEMansouriMTadrosRZniberLAdadiNet al
S.SayedA
Key takeaways from strategies to succeed in the obesity market: Monitor the evolving access landscape Identify high-value partnerships Develop novel HCP strategies Secure clinical and market access strategy differentiation As the healthcare landscape evolves, successful strategies will depend on a data-driven understanding of key adoption trends, access stakeholder priorities (e.g., payer, employer, PBMs), and high-impact technological areas
